BiondVax Pharmaceuticals Ltd. (BVXV) Stock on a Rise, Here’s the Reason
BiondVax Pharmaceuticals Ltd. (BVXV), a development-stage biopharmaceutical company, has surged 12.50% in the premarket trading session. Consequently, BVXV stock is trading at $2.61 at the time of the writing. The surge could be attributed to the successful closing of an underwritten offering of ADSs. On Wednesday, BVXV closed the day at $2.32 after sliding 6.83% […]